Literature DB >> 23700877

The risk of thrombotic events in patients with liver cirrhosis.

Irina Gîrleanu1, Anca Trifan, Camelia Cojocariu, Ana-Maria Sîngeap, C Sfarti, C Stanciu.   

Abstract

AIM: To evaluate the incidence and risk factors for thrombotic events (deep vein thrombosis and portal vein thrombosis) in patients with liver cirrhosis.
MATERIAL AND METHODS: we studied patients diagnosed with liver cirrhosis admitted in our department between January 2010-December 2011, which were divided in two groups: liver cirrhosis with thrombotic events and without thrombotic events.
RESULTS: we included 3108 patients, the incidence of deep vein thrombosis was 0.99% and portal vein thrombosis was 1.51%, the incidence of all thrombotic events was 2.5%. In the univariate analysis serum albumin was significantly lower in cases than controls, and MELD score, mean platelet volume were higher in cases than controls. The presence of sepsis and diabetes mellitus were demonstrated like risk factors by the univariate analysis. In multivariate analysis, albumin level< 3mg/dl (HR=1.65, CI 1.10-2.51, p=0.018) and MELD score >13 (HR=2.94, CI 1.61-5.47, p=0.001) remained independently predictive of thrombotic events.
CONCLUSIONS: The incidence of thrombotic events in patients with liver cirrhosis was 2.5%. Low serum albumin and high MELD score could predict the development of thrombotic events in patients with liver cirrhosis.

Entities:  

Mesh:

Year:  2012        PMID: 23700877

Source DB:  PubMed          Journal:  Rev Med Chir Soc Med Nat Iasi        ISSN: 0048-7848


  4 in total

1.  Reply: Platelet noradrenaline overload - cause of increased noradrenaline spillover in hypertension?

Authors:  Shi-Sheng Zhou; Yiming Zhou
Journal:  Nat Rev Cardiol       Date:  2016-09-22       Impact factor: 32.419

Review 2.  Epidemiology of venous thromboembolism in patients with liver diseases: a systematic review and meta-analysis.

Authors:  Xingshun Qi; Weirong Ren; Xiaozhong Guo; Daiming Fan
Journal:  Intern Emerg Med       Date:  2014-12-04       Impact factor: 3.397

3.  Epidemiology, Risk Factors, and In-Hospital Mortality of Venous Thromboembolism in Liver Cirrhosis: A Single-Center Retrospective Observational Study.

Authors:  Xintong Zhang; Xingshun Qi; Valerio De Stefano; Feifei Hou; Zheng Ning; Jiancheng Zhao; Ying Peng; Jing Li; Han Deng; Hongyu Li; Xiaozhong Guo
Journal:  Med Sci Monit       Date:  2016-03-24

Review 4.  Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma.

Authors:  Alberto Zanetto; Elena Campello; Luca Spiezia; Patrizia Burra; Paolo Simioni; Francesco Paolo Russo
Journal:  Cancers (Basel)       Date:  2018-11-16       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.